You can buy or sell Nuvectra and other stocks, options, ETFs, and crypto commission-free!
Nuvectra Corporation Common Stock, also called Nuvectra, is a neurostimulation medical device company, which engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It operates through Nuvectra segment. Read More The Nuvectra segment is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The company was founded on November 14, 2008 and is headquartered in Plano, TX.
52 Week High
52 Week Low
Simply Wall StMay 8
Have Insiders Been Buying Nuvectra Corporation (NASDAQ:NVTR) Shares?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So we’ll take a look at whether insiders have been buying or selling shares in Nuvectra Corporation (NASDAQ:NVTR). What Is Insider Selling? It’s quite normal to see compan...
Seeking AlphaMay 4
Nuvectra Corporation (NVTR) CEO Fred Parks on Q1 2019 Results - Earnings Call Transcript
Nuvectra Corporation (NASDAQ:NVTR) Q1 2019 Earnings Conference Call May 1, 2019 4:30 PM ET Company Participants Tram Bui - The Ruth Group, Investor Relations Fred Parks - Chief Executive Officer Walter Berger - Chief Operating Officer and Chief Financial Officer Paul Hanchin - President Conference Call Participants Dave Turkaly - JMP Securities Matt Wizman - Raymond James Bruce Nudell - SunTrust Robinson Humphrey Operator Good day, ladies and gentlemen, and welcome to the Q1 2019 Nuvectra earning...
Expected Aug 6, After Hours